Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/16/1999 | WO1999033979A3 Bone marrow secreted proteins and polynucleotides |
09/16/1999 | WO1999033973A3 Cloned octapamine-receptor-producing cells |
09/16/1999 | WO1999033868A3 Human papillomavirus vaccine |
09/16/1999 | WO1999032633A8 Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof |
09/16/1999 | WO1999032625A3 Nucleotide and protein sequence of mammastatin and methods of use |
09/16/1999 | WO1999032621A3 Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof |
09/16/1999 | WO1999031248A9 INSECT-RESISTANT TRANSGENIC PLANTS AND METHODS FOR IMPROVING δ-ENDOTOXIN ACTIVITY AGAINST TARGET INSECTS |
09/16/1999 | WO1999029882A3 Methods for altering the nutritional value of a plant protein, vegetative storage protein, vsp, by altering the amino acid content of proteins |
09/16/1999 | WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
09/16/1999 | WO1999029837B1 Novel dna cloning method relying on the e. coli rece/rect recombination system |
09/16/1999 | WO1999027123A9 Modified sv40 viral vectors |
09/16/1999 | WO1999025846A3 Cellulase produced by actinomycetes and method for producing same |
09/16/1999 | WO1999025831A3 Slit polypeptide and method of modulation of robo with ligands |
09/16/1999 | WO1999024615A3 Diagnostics and therapeutics for chronic obstructive airway disease |
09/16/1999 | WO1999021873A3 Synthesis of polynucleotides having random sequences |
09/16/1999 | WO1999020640A3 High surface density covalent immobilization of oligonucleotide monolayers |
09/16/1999 | WO1999016781A3 Automatable method for preparing samples which can be universally applied |
09/16/1999 | WO1999015684A9 Expression of genes in hematopoietic stem cells in hischaemic conditions |
09/16/1999 | WO1999015666A3 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof |
09/16/1999 | WO1999015657A3 53bp2 complexes |
09/16/1999 | WO1999012411A3 Method for large scale mutagenesis in crop plants |
09/16/1999 | WO1999009177B1 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus |
09/16/1999 | WO1999002693A8 Microbial swollenin protein; dna sequences encoding such swollenins and method of producing such swollenins |
09/16/1999 | WO1998041531A3 Solvent for biopolymer synthesis, solvent microdroplets and methods of use |
09/16/1999 | WO1996012802A9 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
09/16/1999 | DE19912799A1 Super-paramagnetic adsorbent comprising super-paramagnetic iron oxide or ferrite particles in silica gel, especially for separating nucleic acids from liquids e.g. blood |
09/16/1999 | DE19860930A1 Human beta2-adrenergic receptor gene variants, useful for determining an individuals haplotype |
09/16/1999 | DE19815958C1 Non-human mammal - comprises glucocorticoid receptor with altered function in its induced state |
09/16/1999 | DE19811194A1 New nucleic acid expressed at high level in normal prostatic tissue and encoded polypeptides, used to treat cancer and screen for therapeutic agents |
09/16/1999 | DE19811193A1 New nucleic acid expressed at high level in prostatic tumor tissue and encoded polypeptides, useful for treating cancer and screening for therapeutic agents |
09/16/1999 | DE19810879A1 New chimeric polymerase with 5'-3'-polymerase activity, and optionally proofreading activity, used for polymerase chain reactions and sequencing |
09/16/1999 | DE19809978A1 New soluble member of tumor necrosis factor receptor family, useful for identification specific modulators and for treating disease e.g. tumors |
09/16/1999 | CA2421394A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421388A1 Novel poypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421375A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421372A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421364A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421345A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421333A1 Pro 351 polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421329A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421322A1 Pro703 polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421319A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421315A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421286A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421278A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421272A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2363540A1 A gene for transcription factor capable of altering characters of a plant and use thereof |
09/16/1999 | CA2327329A1 Cholesterol recognition sequence |
09/16/1999 | CA2323787A1 Humanized antibody and uses thereof |
09/16/1999 | CA2323632A1 Hla-binding peptides and their uses |
09/16/1999 | CA2323631A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase |
09/16/1999 | CA2323460A1 Plasminogen-related gene b polypeptides |
09/16/1999 | CA2323236A1 Human receptor proteins; related reagents and methods |
09/16/1999 | CA2323109A1 Ribozymes capable of inhibiting the expression of the ccr5 receptor |
09/16/1999 | CA2323097A1 Novel dicarbonyl reductase and genes coding for them |
09/16/1999 | CA2323076A1 Chondrosarcoma associated genes |
09/16/1999 | CA2323074A1 Compositions and methods for the treatment and prevention of metastatic disorders |
09/16/1999 | CA2323070A1 Chitinase chitin-binding fragments |
09/16/1999 | CA2323069A1 Nucleic acid enzyme showing allosteric rna-cleaving activity on target rna |
09/16/1999 | CA2323068A1 Enzymatic preparation of glucose syrup from starch |
09/16/1999 | CA2323060A1 Detection of neoplasia by analysis of saliva |
09/16/1999 | CA2322771A1 Human membrane spanning proteins |
09/16/1999 | CA2322748A1 Vascular endothelial growth factor 2 |
09/16/1999 | CA2322732A1 Secreted proteins and polynucleotides encoding them |
09/16/1999 | CA2322728A1 31 human secreted proteins |
09/16/1999 | CA2322663A1 Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery |
09/16/1999 | CA2322662A1 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
09/16/1999 | CA2322620A1 Compositions and methods for enhanced synthesis of nucleic acid molecules |
09/16/1999 | CA2322508A1 Modified factor viii |
09/16/1999 | CA2322449A1 Biosynthetic genes for spinosyn insecticide production |
09/16/1999 | CA2322232A1 Lyophilized polynucleotide composition, method of preparation, and uses thereof |
09/16/1999 | CA2321677A1 Novel polypeptides and nucleic acids encoding the same which are useful for treating inner ear diseases |
09/16/1999 | CA2321644A1 Novel plant plastid promoter sequence |
09/16/1999 | CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
09/16/1999 | CA2320896A1 Expression of trehalose biosynthetic genes in plants |
09/16/1999 | CA2289023A1 Transformed microorganisms with improved properties |
09/16/1999 | CA2244235A1 A gene for transcription factor capable of altering characters of a plant and use thereof |
09/15/1999 | EP0942000A2 2'Modified oligonucleotides |
09/15/1999 | EP0941369A2 Dna for evaluating the progression potential of cervical lesions |
09/15/1999 | EP0941368A2 Method for detection of metastatic prostate cancer |
09/15/1999 | EP0941365A1 Novel probes for the detection of mycobacteria |
09/15/1999 | EP0941364A1 Process aimed at evidencing the state of a malignant cell and process for treatment |
09/15/1999 | EP0941360A1 Compositions and methods for rapid isolation of plasmid dna |
09/15/1999 | EP0941356A2 Stabilized transient gene expression |
09/15/1999 | EP0941355A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia |
09/15/1999 | EP0941354A1 Syndecan enhancer element and its use for targeting gene expression |
09/15/1999 | EP0941353A1 Methods of producing high-oil seed by modification of starch levels |
09/15/1999 | EP0941352A2 Improvements in or relating to starch content of plants |
09/15/1999 | EP0941351A1 Transgenic plant or plants with a naturally high water content overproducing at least two amino acids of the aspartate family |
09/15/1999 | EP0941349A1 Methods for producing polypeptides in surfactin mutants of bacillus cells |
09/15/1999 | EP0941348A1 Enhanced transport with a plastid membrane transport protein |
09/15/1999 | EP0941347A2 Methods of producing a recombinant protein |
09/15/1999 | EP0941346A1 Secretory immunoglobulin a as a mucosal vaccine delivery system |
09/15/1999 | EP0941345A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
09/15/1999 | EP0941344A1 HUMANIZED ANTI-CD11a ANTIBODIES |
09/15/1999 | EP0941343A1 Pancreatic lipases and/or recombinant colipases and derived polypeptides produced by plants, methods for obtaining them and use thereof |
09/15/1999 | EP0941342A1 Human squalene epoxidase |
09/15/1999 | EP0941341A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
09/15/1999 | EP0941340A1 Transgenic plants having increased starch content |
09/15/1999 | EP0941339A1 Therapeutic gene |